Labwire, Inc. (LBWR) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLabwire, Inc. (LBWR) trades at $0.0004. Labwire, Inc. provides employee screening services to Fortune 500 corporations. It operates through its Labwire Platform, a web-based application designed to streamline regulatory and record management activities related to employee screening. Sector: Technology.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for LBWR: LBWR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Labwire, Inc. (LBWR) Technology Profile & Competitive Position
Labwire, Inc. offers employee screening services, including drug testing and background checks, primarily targeting Fortune 500 corporations through its Labwire Platform. The company operates in the shell companies industry within the financial services sector, providing regulatory compliance and data management solutions for workplace screening.
What Is the Investment Thesis for LBWR?
Labwire, Inc. presents a focused business model within the employee screening services sector, targeting large corporations with its Labwire Platform. The company's ability to streamline regulatory compliance and data management for Fortune 500 companies could drive revenue growth. However, the company's market capitalization is $0.00B, and the beta is -123.31, indicating high volatility and potential risk. The absence of dividends may deter some investors. Growth hinges on expanding its client base and enhancing its platform's capabilities to meet evolving regulatory requirements. The company's small size and limited resources may pose challenges in competing with larger, more established players in the industry. Investors should carefully assess the company's financial stability and growth prospects before considering an investment.
Based on FMP financials and quantitative analysis
LBWR Key Highlights
Labwire, Inc. provides employee screening services, including drug testing and background checks.
- The company's primary offering is the Labwire Platform, a web-based application for streamlining regulatory and record management.
- Labwire focuses on serving Fortune 500 corporations in the United States.
- The company's market capitalization is $0.00B.
- Labwire does not offer a dividend.
Who Are LBWR's Competitors?
LBWR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| JDZG JIADE Limited | $4.84 | +9.75% | — | |
| MASK 3 E Network Technology Group Ltd Class A Ordinary Shares | $0.85 | +4.49% | — | |
| DTST Data Storage Corporation | $3.32 | -1.78% | $7.19M | — |
| LZMH LZ Technology Holdings Limited | $1.20 | +0.84% | $9.42M | — |
| GLE Global Engine Group Holding Limited Ordinary Shares | $0.44 | +3.18% | $10.2M | — |
| CHOW ChowChow Cloud International Holdings Ltd. | $0.56 | +0.81% | $19.9M | — |
| SAIH SAIHEAT Limited | $24.71 | -13.27% | $45.4M | — |
| CTM Castellum, Inc. | $0.63 | +0.41% | $59.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LBWR's Key Strengths?
Specialized focus on employee screening services.
- Web-based Labwire Platform for efficient data management.
- Experience serving Fortune 500 corporations.
- Comprehensive service offerings, including drug testing and background checks.
What Are LBWR's Weaknesses?
Small company size with limited resources (2 employees).
- Dependence on a specific niche market (Fortune 500 corporations).
- Potential vulnerability to changes in regulations or industry standards.
- Limited brand recognition compared to larger competitors.
What Are the Key Risks for LBWR?
Financial-distress signal — its Altman Z-Score of -2.41 sits in the distress zone (elevated bankruptcy risk).
- Limited financial resources and small company size may hinder growth and competitiveness.
- Dependence on a specific niche market (Fortune 500 corporations) could limit growth opportunities.
- Changes in regulations or legal standards could impact the demand for employee screening services.
- Economic downturns could reduce corporate spending on employee screening.
- Trading on the OTC Other tier carries significant risks due to limited disclosure and liquidity.
What Are LBWR's Competitive Advantages?
- Proprietary Labwire Platform: The web-based application streamlines regulatory and record management activities.
- Established relationships with Fortune 500 corporations.
- Expertise in regulatory compliance related to employee screening.
- Customized service offerings tailored to specific client needs.
What Does LBWR Do?
Founded in 2004 and headquartered in Brookshire, Texas, Labwire, Inc., along with its subsidiary, Workplace Screening Services, specializes in providing comprehensive employee screening solutions. The company's core offering is the Labwire Platform, a web-based application designed to streamline and manage the complex regulatory and record-keeping requirements associated with employee screening processes. Labwire's services encompass a wide range of solutions, including drug testing, employee background screening, drug testing policy analysis and updates, medical review, supervisor training and education, and real-time online data management. Labwire assists organizations with customized services, including education, client support systems, background checks, and physicals. The company's Labwire application services facilitate data management and transmission, collection site management and billing consolidation, and custom statistical reports and data transfer. Labwire focuses on serving Fortune 500 corporations in the United States, positioning itself as a provider of regulatory compliance and efficient data management in the employee screening domain. The company's solutions are designed to help businesses maintain safe and compliant workplaces while minimizing administrative burdens.
What Products and Services Does LBWR Offer?
- Provides employee drug testing services.
- Offers employee background screening services.
- Conducts drug testing policy analysis and updates.
- Provides medical review services.
- Offers supervisor training and education programs.
- Provides real-time online data management through Labwire Platform.
- Offers Red Flag Compliance program and drug testing program development.
- Assists organizations with customized education, client support systems, background checks, and physicals.
How Does LBWR Make Money?
- Offers subscription-based access to the Labwire Platform.
- Charges fees for individual employee screening services, such as drug tests and background checks.
- Provides customized consulting services related to employee screening program development and compliance.
- Generates revenue through data management and transmission services.
What Industry Does LBWR Operate In?
Labwire, Inc. operates within the employee screening services industry, which is driven by increasing regulatory compliance requirements and the need for businesses to maintain safe and productive workplaces. The market includes various players offering similar services, ranging from large, established companies to smaller, specialized firms. The industry is influenced by factors such as employment rates, drug use trends, and evolving legal standards. Labwire's focus on technology-driven solutions and its emphasis on serving Fortune 500 corporations position it within a specific niche of the broader employee screening market.
Who Are LBWR's Key Customers?
- Fortune 500 corporations.
- Companies in various industries requiring employee screening services.
- Organizations seeking regulatory compliance in employee screening.
- Businesses needing efficient data management for employee screening records.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Labwire, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.41 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Labwire, Inc. stands at 0.2%, a gauge of how efficiently it converts shareholder capital into profit. Its earnings yield is -0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Labwire, Inc. operates in the Technology sector. It is headquartered in Phoenix, US. The company is led by CEO Shin Hwang. LBWR has traded publicly since 2009.
LBWR Financials
LBWR Latest News
No recent news available for LBWR.
LBWR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LBWR.
Price Targets
Wall Street price target analysis for LBWR.
LBWR MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for LBWR; grades run from A+ (80-100) to F (below 30).
Leadership: Shin Hwang
Unknown
Without further information, it is not possible to provide details about their career history, education, or previous roles.
Track Record: Information about Shin Hwang's track record is not available in the provided data. Without further information, it is not possible to provide details about key achievements, strategic decisions, or company milestones under their leadership.
LBWR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Labwire, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited or no financial disclosure, making it difficult to assess the company's financial health.
- Low trading volume and wide bid-ask spreads, leading to illiquidity and price volatility.
- Potential for price manipulation due to the lack of regulatory oversight.
- Higher risk of fraud or other illegal activities compared to companies listed on major exchanges.
- Limited access to capital and difficulty raising funds.
- Verify the company's legal status and registration.
- Attempt to obtain and review any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other tier stocks.
- Consult with a qualified financial advisor before investing.
- Check for any regulatory actions or legal proceedings involving the company.
- Company has been in operation for several years (founded in 2004).
- Company provides a specific service (employee screening) to a defined market (Fortune 500 corporations).
- Company has a website and contact information.
- Company has a subsidiary (Workplace Screening Services).
- Company offers a technology platform (Labwire Platform).
What Investors Ask About Labwire, Inc. (LBWR) — Technology
What are the main risks for LBWR?
Labwire, Inc. faces several risks, including its small size and limited resources, which may hinder its ability to compete with larger, more established players in the employee screening services market.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available for this OTC-traded company.